Unnecessary workup of asymptomatic neonates in the era of Group B streptococcus prophylaxis

Infectious Diseases in Obstetrics and Gynecology

Volumn 2010, Issue , 2010, Pages

  Buckler, Brad ^a   Bell, Jason ^a   Sams, Ralph ^b   Cagle, William ^a   Bell, Sue Anne ^a   Allen, Carla ^a   Sutherland, Don ^a   Bhatia, Jatinder ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b MERCER UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; C REACTIVE PROTEIN; GENTAMICIN;

ARTICLE; BIRTH; BLOOD CELL COUNT; BLOOD CULTURE; COHORT ANALYSIS; GROUP B STREPTOCOCCAL INFECTION; HEALTH CARE COST; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN SCREENING; PRIORITY JOURNAL; RETROSPECTIVE STUDY; UNITED STATES;

ANTI-BACTERIAL AGENTS; BACTEREMIA; BLOOD CELL COUNT; C-REACTIVE PROTEIN; COHORT STUDIES; FEMALE; HUMANS; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RETROSPECTIVE STUDIES; SEPSIS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE;

EID: 77957857236     PISSN: 10647449     EISSN: 10980997     Source Type: Journal    
DOI: 10.1155/2010/369654     Document Type: Article

References (11)

1. Tumbaga P. F., Philip A. G., Perinatal Group B streptococcal infections and the new Guidelines: an update NeoReviews 2006 7 e534 e530
2. Anderson-Berry A. L., Bellig L. L., Neonatal sepsis Emedicine 2008
3. Ottolini M. C., Lundgren K., Mirkinson L. J., Cason S., Ottolini M. G., Utility of complete blood count and blood culture screening to diagnose neonatal sepsis in the asymptomatic at risk newborn Pediatric Infectious Disease Journal 2003 22 5 430 434
4. Schrag S., Gorwitz R., Fultz-Butts K., Schuchat A., Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC Morbidity and Mortality Weekly Report 2002 51 11 1 22
5. Center for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infection Program Network, Group B Streptococcus, 2000
6. Center for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infection Program Network, Group B Streptococcus, 2006
7. Saifer R. A., Robins S. H., Picone C. M., Tafari N., Blood culture screening of newborns at risk for early onset neonatal group B streptococcal disease Pediatric Research 2002 51, supplement 304A
8. De Cueto M., Sanchez M.-J., Sampedro A., Miranda J.-A., Herruzo A.-J., Rosa-Fraile M., Timing of intrapartum ampicillin and prevention of vertical transmission of group B streptococcus Obstetrics and Gynecology 1998 91 1 112 114
9. McNanley A. R., Glantz J. C., Hardy D. J., Vicino D., The effect of intrapartum penicillin on vaginal group B streptococcus colony counts American Journal of Obstetrics and Gynecology 2007 197 6 583 e1
10. Bloom S. L., Cox S. M., Bawdon R. E., Gilstrap L. C., Ampicillin for neonatal group B streptococcal prophylaxis: how rapidly can bactericidal concentrations be achieved? American Journal of Obstetrics and Gynecology 1996 175 4 974 976
11. Campbell N., Eddy A., Darlow B., Stone P., Grimwood K., The prevention of early-onset neonatal group B streptococcus infection: technical report from the New Zealand GBS Consensus Working Party New Zealand Medical Journal 2004 117 1200